Clinical trials: New Daily Persistent Headache (NDPH)
New Daily Persistent Headache (NDPH), New Daily Persistent Headache
New Daily Persistent Headache Survey
Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache.
- Trial name
- NDPH (NCT05984719)
- Where
- United States
- Volunteers
- 803 people
- Sponsor
- The University of Texas Health Science Center, Houston
New Daily Persistent Headache (NDPH)
Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)
The goal of this study is to examine the effects of the Remote Electrical Neuromodulation (REN) device on adolescents ages 12-17 who have been diagnosed with New Daily Persistent Headache (NDPH).
- Trial name
- NCT05310227
- Testing
- Nerivio
- Where
- United States
- Sponsor
- Children's National Research Institute
New Daily Persistent Headache (NDPH)
Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children
New daily persistent headache (NDPH) is a primary headache disorder characterized by the daily and unremitting headache pain patients experience with a distinct onset.
- Trial name
- EMCS-NDPH (NCT03447782)
- Testing
- Naltrexone HCl (Bulk) Powder
- Where
- United States
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Boston Children's Hospital
New Daily Persistent Headache, New Daily Persistent Headache (NDPH)
New Daily Persistent Headache Biomarkers Study
New daily persistent headache is a debilitating syndrome which is seldom researched, poorly understood, and without effective treatments. Chronic migraine is a more common but similarly disabling disorder.
- Trial name
- NDPH (NCT04260087)
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Albert Einstein College of Medicine